The participants with T2DM had an increased hazard for all secondary endpoints compared with the participants without diabetes, although this did not reach statistical significance for spontaneous myocardial infarction, cardiovascular death, and ischemic stroke ( Table 2 ).
← all excerpts
Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial.
1
—
—